Model N Announces New Chief Marketing Officer

SAN MATEO, Calif.–(BUSINESS WIRE)–Model N, Inc. (NYSE: MODN), the leading provider of cloud revenue management solutions for the pharmaceutical, medical device, high-tech manufacturing and semiconductor industries, today announced that Dave Michaud has joined as Chief Marketing Officer. Mr. Michaud brings over two decades of marketing leadership experience at high-growth software companies such as Oracle, VMware, Taleo, and Eloqua.

“We are thrilled to have Dave join Model N as our Chief Marketing Officer,” said Jason Blessing, Chief Executive Officer at Model N. “His extensive experience developing and executing go-to-market strategies will help us grow and deepen our leadership in our core markets of life sciences and high tech. Dave is a proven marketing executive with a strong cultural fit who will help take our marketing efforts to the next level.”

“I am very happy to be joining the Model N team,” said Michaud. “The company serves the complex needs of some of the world’s biggest companies and I am excited to help them on their journey. I look forward to telling our story, deepening our customer relationships, and driving global demand.”

Dave brings over two decades of senior marketing leadership in high-growth software companies. He is a marketing executive with a proven track record creating categories, entering new markets, driving market leadership, and building world-class teams. Most recently he was senior vice president of marketing at Plex. Dave previously held marketing leadership positions at Taleo, Eloqua, VMware, PeopleSoft, and Oracle.

About Model N

Model N is a leading provider of cloud revenue management solutions for life sciences and high tech companies. Driving mission-critical business processes such as pricing, quoting, contracting, regulatory compliance, rebates and incentives, our software helps companies know and grow their true top line and maximize every revenue moment at speed and scale. With deep industry expertise, Model N supports the complex business needs of the world’s leading brands in pharmaceutical, medical technology, semiconductor, and high-tech manufacturing across more than 100 countries, including Johnson & Johnson, AstraZeneca, Novartis, Microchip Technology and ON Semiconductor. For more information, visit www.modeln.com.

Contacts

Sherri Walkenhorst

801.373.7888

swalkenhorst@modeln.com

Staff

Recent Posts

CannaPharmaRX Provides Corporate Update and Outlines Growth Strategy for 2026

CALGARY, AB / ACCESS Newswire / January 12, 2026 / CannaPharmaRX, Inc. (OTC PINK:CPMD), an…

6 hours ago

TempraMed Closes C$2.5 Million Fully Subscribed Private Placement

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…

9 hours ago

TruuCONNECT NJ Statewide Digital Hub Empowers Users to Find Verified, Local Community Resources and Support – Anonymously and in Real Time

MOUNT LAUREL, N.J., Jan. 12, 2026 /PRNewswire/ -- Born out of a partnership between the…

9 hours ago

Nuvo Unveils Large-Scale AI-Ready Pregnancy Dataset Built on Real-World Maternal and Fetal Physiology

Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into…

9 hours ago

Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision…

9 hours ago

RxAnte Announces Strategic Growth Investment from Primus Capital

PORTLAND, Maine, Jan. 12, 2026 /PRNewswire/ -- RxAnte, the leading provider of analytics, software, and…

9 hours ago